Nanotechnology Drug Delivery Market Forecasted to Reach US$ 142.8 Billion by 2028 with 7.9% CAGR

The global nanotechnology drug delivery market, valued at US$ 77.1 billion in 2020, is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028. By the end of 2028, the market is expected to surpass US$ 142.8 billion, driven by advancements in nanotechnology and increasing demand for more effective drug delivery systems.

Controlled drug release at the target site for advanced medicine/drug formulations is proving to be major advantage to patients, finds an in-depth study on the nanotechnology drug delivery market. The opportunities in nano delivery systems have increased due to potential of these in improving the efficacy of novel and old drugs. For instance, nanotechnology-mediated drug delivery holds a major interest in cancer cure, asserts the study on the nanotechnology drug delivery market.

Dive Deeper into Data: Get Your In-Depth Sample Now! - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1822

Natural compounds in particular have attracted considerable attention among drug developers in the nanotechnology drug delivery market, mainly due to their macromolecular specificity and low toxicity. Stridently, many drugs based on natural compounds have notably failed to emerge successful across clinical trial phases. The use of nanotechnology is paving the way to better drug delivery systems for targeting these to specific body parts, hence, improving their success rates.

Key Findings of Nanotechnology Drug Delivery Market Study

• Nanoparticle-Based Drug Delivery in Cancer Therapy Generates Massive Lucrative Avenues: Opportunities in the cardiovascular/pathology segment are projected to expand at remarkable CAGR during the forecast period (2021–2028). The oncology segment accounted for a major share of the global nanotechnology drug delivery market in 2020, find the authors of the TMR study. Rise in use of natural compounds for treating cancer has spurred investment in the development of target-based drug discovery and drug delivery.
  
  
• Advantages of Target-Specific Drug Delivery Systems Spurs Demand: Controlled drug release at the target site is one of the key advantages of nano delivery systems. The use of these in target-oriented delivery of precise medicines is catalyzing revenue potential for pharmaceutical companies developing medicines for chronic diseases. Of note, natural product-based drug discovery has attracted special attention. In recent years, many nanomedicines approved by key regulatory agencies such as the FDA. Contract research organizations have concentrated their investments in target-based drug discovery, and thus are catalyzing the revenue potential in the nanotechnology drug delivery market.

Nanotechnology Drug Delivery Market: Key Drivers

• Nanomedicines are increasingly making a mark in next-gen drug delivery and inventions for various diseases. Massive R&D on novel drugs for major diseases such as cancer, diabetes, cardiovascular, inflammatory, and microbial diseases, is spurring industry interest in the nanotechnology drug delivery market.
  
  
• Pharmaceutical companies have intensified their efforts on reformulation of new and old orphaned compounds. This is driving the need for new drug delivery compounds, thus is boosting the nanotechnology drug delivery market.

Nanotechnology Drug Delivery Market: Key Regional Dynamics

• North America held a leading share of the global nanotechnology drug delivery market in 2020. Incredible advancements in drug delivery systems in the U.S. especially for chronic diseases have fueled the revenue growth, find the authors in the in-depth TMR study.
  
  
• Asia Pacific and Latin America are anticipated to be lucrative nanotechnology drug delivery markets. Rise in spending on cancer treatment and substantial R&D on drug delivery systems are propelling innovation in nanomedicines in the regional markets.

Nanotechnology Drug Delivery Market: Prominent Players

Some of the key players in the nanotechnology drug delivery market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Perrigo Company plc, Novartis International AG, Merck & Co., Inc., Johnson & Johnson, Celgene Corporation, Amgen, Inc., and AbbVie, Inc.

Discover Key Insights – Visit Our Report Now! https://www.transparencymarketresearch.com/nanotechnology-drug-delivery.html

Global Nanotechnology Drug Delivery Market: Segmentation

Nanotechnology Drug Delivery Market, by Technology

• Nanocrystals
• Nanoparticles
• Dendrimers
• Gold Nanoparticles
• Fullerenes
• Liposomes
• Micelles
• Nanotubes
• Others

Nanotechnology Drug Delivery Market, by Application

• Neurology
• Oncology
• Cardiovascular/Physiology
• Anti-Inflammatory/Immunology
• Anti-Infective
• Others (Hematology, Ophthalmology, etc.)

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Explore Latest Research Reports by Transparency Market Research:

C-arms Market – The C-arms market is projected to grow at a CAGR of 5.9% from 2024 to 2034 and cross US$ 5.1 Billion by the end of 2034.

Cell Therapy Market – The cell therapy market is projected to advance at a CAGR of 20.8% from 2024 to 2034 and reach more than US$ 44.6 Billion by the end of 2034.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com    

Email: sales@transparencymarketresearch.com

Follow Us: LinkedIn| Twitter| Blog | YouTube